Community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in adults.

We herein describe a case of community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae (MRMP) in an adult who responded poorly to macrolide antibiotics, progressively deteriorated to acute respiratory failure and then responded effectively to a fluoroquinolone. In a series of 14 patients with M. pneumoniae pneumonia, 11 were infected with MRMP. In seven of the eight cases of MRMP initially treated with macrolides, the patients did not improve, and a marked improvement was observed only after the antibiotic regimen was modified to include fluoroquinolones or tetracyclines. Nationwide surveillance should provide important information regarding the prevalence and empirical treatment of MRMP infection in adults.

[1]  N. Miyashita,et al.  Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Adolescents and Adults: Clinical Findings, Drug Susceptibility, and Therapeutic Efficacy , 2013, Antimicrobial Agents and Chemotherapy.

[2]  H. Sakata,et al.  Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Y. Nishizawa,et al.  Therapeutic Efficacy of Macrolides, Minocycline, and Tosufloxacin against Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Pediatric Patients , 2012, Antimicrobial Agents and Chemotherapy.

[4]  K. Yuen,et al.  Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia , 2010, European Respiratory Journal.

[5]  B. Cao,et al.  High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Morozumi,et al.  Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia , 2010, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[7]  K. Ariyoshi,et al.  Adult community‐acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae , 2009, Respirology.

[8]  N. Miyashita,et al.  Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia , 2012, BMC Infectious Diseases.

[9]  N. Miyashita,et al.  Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age , 2011, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.